Why is Boston Bio falling/rising?

As of 12-Sep, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.85, which reflects a decrease of 0.41 or 4.96%. The stock has underperformed its sector by 6.01% today and has been on a downward trend for the last two days, accumulating a total loss of 5.88% during this period. Additionally, the stock's performance over the past week shows a significant drop of 8.61%, while it has also underperformed the benchmark Sensex, which has gained 1.48% in the same timeframe. The delivery volume has seen a drastic decline of 85.81% compared to the 5-day average, indicating falling investor participation, which may contribute to the stock's recent struggles.
In the broader market context, while the Sensex has shown a positive return of 1.48% over the past week, Boston Bio's performance has been notably negative, highlighting a stark contrast between the stock and the benchmark. The stock's moving averages indicate that it is currently lower than the 5-day, 20-day, and 200-day moving averages, which may signal bearish sentiment among investors. The lack of available positive or negative dashboard data further complicates the analysis of specific factors influencing the stock's movement, but the overall trend suggests a challenging environment for Boston Bio Systems Ltd in the current market landscape.